1. Home
  2. SXTP vs CLDI Comparison

SXTP vs CLDI Comparison

Compare SXTP & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$0.49

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

SELL

Current Price

$0.60

Market Cap

1.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXTP
CLDI
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SXTP
CLDI
Price
$0.49
$0.60
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $3.70
N/A
AVG Volume (30 Days)
★ 321.8K
33.1K
Earning Date
11-27-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.77
N/A
EPS
★ N/A
N/A
Revenue
★ $1,005,471.00
$45,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$70.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 65.49
N/A
52 Week Low
$0.34
$0.09
52 Week High
$8.62
$3.10

Technical Indicators

Market Signals
Indicator
SXTP
CLDI
Relative Strength Index (RSI) 29.77 31.43
Support Level N/A $0.37
Resistance Level $1.01 $0.79
Average True Range (ATR) 0.11 0.07
MACD -0.03 0.01
Stochastic Oscillator 6.02 0.05

Price Performance

Historical Comparison
SXTP
CLDI

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

Share on Social Networks: